GRP
ATYR

Global Retirement Partners’s aTyr Pharma ATYR Stock Holding History

Global Retirement Partners’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$216 – 4447
2025
Q3 		$216 Hold
300
– – ﹤0.01% 3732
2025
Q2 		$1.52K Buy
+300
New +$1.18K ﹤0.01% 3331

Other funds holding ATYR

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Global Retirement Partners's ATYR Position: Q4 2025 in Review

Global Retirement Partners sold out of aTyr Pharma (ATYR) in Q4 2025, closing a stake of 300 shares — an estimated $216 sold.

Global Retirement Partners first reported a position in ATYR in Q2 2025 and held it in 2 quarters. The position peaked at $1.52K in Q2 2025. 84 funds tracked by Wall St. Rank hold ATYR as of Q4 2025.

  • Global Retirement Partners reported no remaining aTyr Pharma position as of Q4 2025 after selling out during the quarter.
  • Global Retirement Partners sold 300 aTyr Pharma shares in Q4 2025, an estimated $216.
  • Global Retirement Partners first reported a position in aTyr Pharma in Q2 2025 and held it in 2 quarters.
  • Global Retirement Partners's aTyr Pharma position peaked at $1.52K in Q2 2025.
  • 84 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.